GO:0035303 regulation of dephosphorylation: Signaling Control, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0035303 regulation of dephosphorylation describes any process that modulates the frequency, rate or extent of removal of phosphate groups from a molecule.
• Dephosphorylation is catalyzed by phosphatases and is counterbalanced by kinases; its regulation controls signaling amplitude and duration.
• Key regulators include PP2A, calcineurin, SHP-2, DUSP6, and Cdk1-specific phosphatases.
• Dysregulated dephosphorylation contributes to cancer, immune disorders, and metabolic diseases.
• CRISPR knockout, point mutation, knock-in, and overexpression models enable causal dissection of dephosphorylation regulators.
• EDITGENE provides end-to-end CRISPR services to study regulation of dephosphorylation in any cell type.
Description
Regulation of dephosphorylation (GO:0035303) is a fundamental biological process that controls the removal of phosphate groups from proteins and other molecules. Because phosphorylation is a major post-translational modification, its reversal by phosphatases must be tightly regulated to ensure proper signal transduction, cell cycle progression, and metabolic homeostasis. This GO term encompasses all mechanisms that modulate the frequency, rate, or extent of dephosphorylation, including phosphatase recruitment, activation, inhibition, and substrate targeting. Researchers study this process to understand how cells decode signals, how diseases arise from aberrant phosphatase activity, and how to design targeted therapies.
regulation of dephosphorylation At A Glance
| GO ID | GO:0035303 |
|---|---|
| GO term | regulation of dephosphorylation |
| Ontology | biological_process |
| Synonym | none |
| Major function | Modulates the removal of phosphate groups from molecules, thereby controlling signaling and cellular responses. |
| Key enzymes | Protein phosphatases such as PP2A, calcineurin, SHP-2, DUSP6, and Cdk1 phosphatases. |
| Substrates | Phosphorylated proteins including GSK3β, NFAT, STAT5, Drp1, and Notch1. |
| Disease relevance | Cancer, immune dysregulation, metabolic disorders, and neurological conditions. |
| Research methods | CRISPR knockout, point mutation, knock-in, overexpression, phosphoproteomics, and live-cell imaging. |
What Is GO:0035303?
GO:0035303 regulation of dephosphorylation is defined as any process that modulates the frequency, rate or extent of removal of phosphate groups from a molecule. In practice, this includes the regulation of phosphatase enzymes (e.g., PP2A, calcineurin, SHP-2) and their access to substrates, as well as the signaling pathways that control these phosphatases.
Why Is regulation of dephosphorylation Important in Cell Biology?
Regulation of dephosphorylation is critical because it determines the duration and intensity of phosphorylation-dependent signals. Dysregulation of phosphatases or their regulators leads to diseases such as cancer, where DUSP6 modulates Notch1 signaling, and immune disorders, where SHP-2 controls STAT5 dephosphorylation. Understanding this process provides insights into fundamental cell biology and identifies therapeutic targets.
• Controls cell cycle progression via Cdk1 tyrosine dephosphorylation.
• Regulates immune cell signaling through STAT5 and NFAT dephosphorylation.
• Modulates osteoclast function via PP2A-mediated GSK3β dephosphorylation.
• Influences ferroptosis in glioma through Drp1 dephosphorylation.
• Affects hematopoietic cell signaling and gene expression.
• Plays a role in bacterial two-component signaling via MutT1-mediated dephosphorylation.
• DUSP6 regulates Notch1 signaling in colorectal cancer.
• Provides targets for cancer therapy and immune modulation.
• Essential for neuronal development and synaptic plasticity.
• Offers opportunities for CRISPR-based functional studies.
What Happens During regulation of dephosphorylation?
Phosphatase Recruitment and Activation
In simple terms: Cells bring the right phosphatase to the right place at the right time.
Regulation of dephosphorylation often begins with the recruitment of a phosphatase to its substrate. For example, PP2A is recruited to GSK3β to mediate its dephosphorylation in osteoclasts. Similarly, calcineurin dephosphorylates NFAT, leading to its nuclear import and subsequent inhibition of Skp2-mediated degradation. This step ensures substrate specificity and temporal control.
Substrate Recognition and Dephosphorylation
In simple terms: The phosphatase removes the phosphate tag from the target protein.
Once recruited, the phosphatase catalyzes the removal of the phosphate group. SHP-2 dephosphorylates STAT5, thereby regulating its activity. In glioma, Hsp90 induces Acsl4-dependent ferroptosis via dephosphorylation of Ser637 on Drp1. This step is highly specific and is controlled by the phosphatase's active site and regulatory subunits.
Feedback and Crosstalk with Kinases
In simple terms: Dephosphorylation is balanced by kinases that add phosphates back.
Regulation of dephosphorylation is intertwined with kinase activity. For instance, Cdk1 tyrosine dephosphorylation is redundantly regulated in Saccharomyces cerevisiae, ensuring proper cell cycle progression. DUSP6, a dual-specificity phosphatase, regulates Notch1 signaling in colorectal cancer, highlighting crosstalk between phosphorylation and dephosphorylation pathways.
Integration into Cellular Signaling Networks
In simple terms: Dephosphorylation events are part of larger signaling circuits.
Dephosphorylation is integrated into signaling networks that control gene expression and cell fate. In hematopoietic cells, signaling pathways and regulation of gene expression are tightly linked to dephosphorylation events. Mycobacterial MutT1-mediated dephosphorylation of sensor histidine kinases reveals a new link in two-component signaling regulation.
Key Genes Involved in GO:0035303 regulation of dephosphorylation
The following genes and proteins are key players in the regulation of dephosphorylation, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PPP2CA | Catalytic subunit of PP2A; dephosphorylates GSK3β | Osteoclast function and bone biology |
| PPP3CA | Calcineurin A; dephosphorylates NFAT | Immune regulation and cancer |
| PTPN11 | SHP-2 tyrosine phosphatase; dephosphorylates STAT5 | Hematopoietic signaling and leukemia |
| DUSP6 | Dual-specificity phosphatase; regulates Notch1 | Colorectal cancer |
| CDC25 | Cdk1 tyrosine phosphatase; regulates cell cycle | Cell cycle control in yeast |
| DNM1L | Drp1; regulated by dephosphorylation at Ser637 | Glioma ferroptosis |
| GSK3B | Substrate of PP2A; involved in Wnt signaling | Osteoclast differentiation |
| NFATC1 | Transcription factor dephosphorylated by calcineurin | Immune response and cancer |
| STAT5A | Transcription factor dephosphorylated by SHP-2 | Hematopoiesis |
| NOTCH1 | Receptor regulated by DUSP6-mediated dephosphorylation | Colorectal cancer |
| ACSL4 | Involved in ferroptosis via Drp1 dephosphorylation | Glioma |
| HSP90AA1 | Chaperone that induces Drp1 dephosphorylation | Glioma |
| MUTT1 | Mycobacterial phosphatase for histidine kinases | Bacterial signaling |
| SKP2 | Degradation target regulated by NFAT dephosphorylation | Cancer |
| RHOA | Small GTPase regulated by PP2A-mediated GSK3β dephosphorylation | Osteoclast function |
| PTPN6 | SHP-1; related phosphatase in hematopoietic cells | Hematopoietic signaling |
| CDK1 | Kinase whose dephosphorylation is regulated | Cell cycle |
How Is regulation of dephosphorylation Regulated?
Regulation of dephosphorylation is itself controlled by multiple mechanisms. Phosphatase activity can be modulated by regulatory subunits, post-translational modifications, and interacting proteins. For example, PP2A activity is regulated by its B subunits, which target it to specific substrates like GSK3β. Calcineurin is activated by calcium/calmodulin, linking dephosphorylation to calcium signaling. DUSP6 expression and activity are controlled by growth factor signaling pathways. Additionally, Hsp90 regulates Drp1 dephosphorylation in glioma, showing chaperone involvement.
regulation of dephosphorylation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| DUSP6 | Colorectal cancer | Knockout in HCT116 cells |
| PPP3CA | Immune disorders, cancer | Knockout in Jurkat T cells |
| PTPN11 | Leukemia, Noonan syndrome | Point mutation in hematopoietic stem cells |
| PPP2CA | Bone diseases | Knockout in osteoclast precursors |
| DNM1L | Glioma | Overexpression of phospho-mutant in U87 cells |
Cancer
Dysregulation of dephosphorylation is implicated in multiple cancers. DUSP6 regulates Notch1 signaling in colorectal cancer, affecting tumor growth. Calcineurin-mediated NFAT dephosphorylation inhibits Skp2 degradation, influencing cell cycle progression. In glioma, Hsp90-induced Drp1 dephosphorylation promotes ferroptosis, a form of cell death relevant to therapy.
Immune and Hematopoietic Disorders
SHP-2-mediated STAT5 dephosphorylation is critical for hematopoietic cell signaling, and its dysregulation can lead to leukemia and immune deficiencies. Calcineurin/NFAT signaling is essential for T-cell activation, and its modulation is a target for immunosuppressive drugs. Signaling pathways in hematopoietic cells are tightly linked to dephosphorylation events.
Metabolic and Bone Diseases
PP2A-mediated GSK3β dephosphorylation is required for protocadherin-7-dependent regulation of RhoA in osteoclasts, linking dephosphorylation to bone remodeling. This pathway may be relevant to osteoporosis and other bone diseases.
From regulation of dephosphorylation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of DUSP6 affect Notch1 signaling? | DUSP6 knockout colorectal cancer cell line |
| How does PP2A dephosphorylate GSK3β? | PPP2CA knockout osteoclasts |
| What is the role of SHP-2 in STAT5 regulation? | PTPN11 point mutant hematopoietic cells |
| Does Drp1 Ser637 dephosphorylation induce ferroptosis? | DNM1L knock-in phospho-deficient mutant in glioma cells |
| Is calcineurin required for NFAT dephosphorylation? | PPP3CA knockout T cells |
| How does MutT1 regulate histidine kinase? | Mycobacterial MutT1 overexpression |
How to Study the regulation of dephosphorylation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Phosphoproteomics | Global phosphorylation changes | Identify substrates of phosphatases |
| CRISPR knockout screen | Gene essentiality and pathway regulators | Discover dephosphorylation regulators |
| Western blot with phospho-antibodies | Specific protein phosphorylation | Validate dephosphorylation events |
| FRET biosensors | Real-time dephosphorylation dynamics | Live-cell signaling studies |
| Co-immunoprecipitation | Protein-protein interactions | Confirm phosphatase-substrate binding |
| In vitro phosphatase assay | Enzymatic activity | Measure phosphatase kinetics |
| RNA-seq | Transcriptional changes | Assess downstream effects |
Phosphoproteomics
Mass spectrometry-based phosphoproteomics allows global profiling of phosphorylation and dephosphorylation events. It can identify substrates of specific phosphatases and quantify changes upon genetic perturbation.
CRISPR Screens
Genome-wide CRISPR knockout screens can identify regulators of dephosphorylation pathways. For example, screens in cancer cells can reveal phosphatases or their regulators that affect drug sensitivity.
Live-Cell Imaging
Fluorescent biosensors and FRET-based reporters enable real-time visualization of dephosphorylation dynamics in living cells. This is useful for studying rapid signaling events.
Biochemical Assays
In vitro phosphatase assays using recombinant proteins and phospho-substrates measure specific activity and kinetics. Co-immunoprecipitation can confirm physical interactions between phosphatases and substrates.
How CRISPR Can Be Used to Study GO:0035303 regulation of dephosphorylation
Knockout
CRISPR knockout of phosphatase genes (e.g., PPP2CA, DUSP6) allows researchers to assess loss-of-function phenotypes and identify essential roles in dephosphorylation pathways.
Point Mutation
Introducing point mutations in phosphatase active sites or regulatory domains (e.g., PTPN11) can dissect specific functions without completely abolishing protein expression.
Knock-in
Knock-in of phospho-deficient or phospho-mimetic mutants (e.g., Drp1 Ser637) enables precise interrogation of dephosphorylation sites in vivo.
Overexpression
Overexpression of phosphatases or their regulators (e.g., MutT1) can reveal gain-of-function effects and dominant-negative interactions.
How EDITGENE Supports regulation of dephosphorylation Research
Researchers studying regulation of dephosphorylation-related genes often need to determine whether a candidate gene is causally involved in a specific signaling pathway or disease. EDITGENE provides comprehensive CRISPR services to generate precisely engineered cell models for such studies.
Contact EDITGENE today to design your custom CRISPR model for regulation of dephosphorylation research.
Frequently Asked Questions About regulation of dephosphorylation
What is GO:0035303 regulation of dephosphorylation?
GO:0035303 is a Gene Ontology biological process term defined as any process that modulates the frequency, rate or extent of removal of phosphate groups from a molecule.
What genes are involved in regulation of dephosphorylation?
Key genes include PPP2CA, PPP3CA, PTPN11, DUSP6, CDC25, and DNM1L, among others.
How is dephosphorylation regulated in cells?
It is regulated by phosphatase recruitment, activation, substrate recognition, and crosstalk with kinases.
What diseases are linked to dephosphorylation dysregulation?
Cancer, immune disorders, and bone diseases are linked to aberrant dephosphorylation.
What methods study regulation of dephosphorylation?
Phosphoproteomics, CRISPR screens, live-cell imaging, and biochemical assays are commonly used.
What is the role of PP2A in dephosphorylation?
PP2A dephosphorylates substrates like GSK3β, regulating osteoclast function.
How does calcineurin regulate dephosphorylation?
Calcineurin dephosphorylates NFAT, controlling its nuclear localization and degradation.
What is the function of SHP-2 in dephosphorylation?
SHP-2 dephosphorylates STAT5, regulating hematopoietic signaling.
How does DUSP6 regulate Notch1 signaling?
DUSP6 dephosphorylates Notch1, affecting colorectal cancer progression.
Can CRISPR be used to study regulation of dephosphorylation?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are powerful tools for dissecting dephosphorylation pathways.
Conclusion
Regulation of dephosphorylation (GO:0035303) is a central biological process that controls signaling dynamics and cellular homeostasis. Its dysregulation underlies various diseases, making it a prime target for research and therapeutic intervention. With advanced CRISPR tools and bioinformatics, EDITGENE supports researchers in uncovering the mechanisms and disease relevance of dephosphorylation regulators.
References
- 1. Miao Z et al.. 2022. Hsp90 induces Acsl4-dependent glioma ferroptosis via dephosphorylating Ser637 at Drp1.. Cell Death Dis 13(6):548 PMID: 35697672
- 2. Kim H et al.. 2023. PP2A-Mediated GSK3β Dephosphorylation Is Required for Protocadherin-7-Dependent Regulation of Small GTPase RhoA in Osteoclasts.. Cells 12(15) PMID: 37566044
- 3. Kennedy EK et al.. 2016. Redundant Regulation of Cdk1 Tyrosine Dephosphorylation in Saccharomyces cerevisiae.. Genetics 202(3):903-10 PMID: 26715668
- 4. Emam EAF et al.. 2025. Mycobacterial MutT1-mediated dephosphorylation of the sensor histidine kinases reveals a new link in the regulation of the two-component signaling.. Nucleic Acids Res 53(16) PMID: 40902001
- 5. Bogush D et al.. 2023. Signaling pathways and regulation of gene expression in hematopoietic cells.. Adv Biol Regul 88:100942 PMID: 36621151
- 6. Hanaki S et al.. 2024. Dephosphorylation of NFAT by Calcineurin inhibits Skp2-mediated degradation.. J Biochem 175(3):235-244 PMID: 38030387
- 7. Yu CL et al.. 2000. Cytosolic tyrosine dephosphorylation of STAT5. Potential role of SHP-2 in STAT5 regulation.. J Biol Chem 275(1):599-604 PMID: 10617656
- 8. Png CW et al.. 2024. DUSP6 regulates Notch1 signalling in colorectal cancer.. Nat Commun 15(1):10087 PMID: 39572549
